BOLT-DVT, a recent prospective, multicenter Investigational Device Exemption (IDE) trial,...
Read MoreFDA
BOLT-DVT, a recent prospective, multicenter Investigational Device Exemption (IDE) trial,...
Read MoreTemporary knee spacer delivers antibiotics directly to an infected joint...
Read MoreFor the first time, U.S. CardioMEMS patients will be able...
Read MoreThe new clearances expand its reach to additional brain targets...
Read MoreMobile platform combines smartphone technology, a proprietary light-occluding headset, and...
Read MoreGlobal pharmaceutical leader Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN)...
Read MoreNew addition to rectal spacing portfolio offers flexible hydrogel placement,...
Read MoreThe designation covers hospitalized newborns and infants from birth to...
Read MoreThe patent protects the mechanism that allows clinicians to start,...
Read MoreTriton 1 Robotic Endoscopy System 510K-Cleared for Diagnostic and Therapeutic...
Read MoreThe designation covers Bright Path's end-to-end U.S. production of two...
Read MoreClearance brings full cerebral and systemic embolic protection to patients...
Read More